Heart Failure Clinical Trials

Find Heart Failure Clinical Trials Near You

Effectiveness of Mobile-Based Telemedicine on Health-Related Quality of Life Among Patients With Chronic Heart Failure: Protocol for a Quasi-Experimental Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Chronic heart failure (CHF) is a long-term condition in which the heart is unable to pump blood effectively. It can cause symptoms such as shortness of breath, fatigue, swelling in the legs, and reduced ability to perform daily activities. These problems often reduce a patient's quality of life and may lead to frequent hospital visits. This study will assess whether a mobile-based telemedicine program can improve the health-related quality of life of patients with chronic heart failure in Ethiopia. In this study, 70 adult patients with chronic heart failure will be included. They will be divided into two groups: 35 patients will receive routine care plus mobile-based telemedicine support, and 35 patients will receive routine care only. The mobile-based telemedicine program will include health education, medication reminders, lifestyle advice, and follow-up support delivered through phone calls and text messages over an 8-week period. Patients' quality of life will be measured at the beginning of the study and again after 8 weeks using a standard questionnaire called the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The main goal of the study is to determine whether mobile-based telemedicine improves quality of life compared with routine care alone. The study may also help improve self-care behaviors, medication adherence, and symptom control among patients with heart failure. The findings may provide evidence to support the use of mobile health technologies as a simple and scalable approach to improve heart failure care in Ethiopia.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Adults aged 18-65 years who will be diagnosed with CHF (NYHA class II⁃III)

• Patients with reduced left ventricular ejection fraction LVEF ≤ 40%

• Patient who will have access to a mobile phone and will be able to use it

• Patients who will be able to communicate in Amharic, Oromic, or English

• Patients who will provide written informed consent

• Patients who will be diagnosed with HF lasting ≥ 6 months, to be confirmed by echocardiography and clinical assessment

• Patients with no contraindications for mild to moderate physical activity

Locations
Other Locations
Ethiopia
Menelik II Comprehensive Specialized Hospital
RECRUITING
Addis Ababa
Contact Information
Primary
Gudisa Bereda, B.Pharm, MPH cand
gudisabareda95@gmail.com
+251-913118492
Backup
Javed Ahamad, Professor
jas.hamdard@gmail.com
07512372960
Time Frame
Start Date: 2026-03-02
Estimated Completion Date: 2026-08-21
Participants
Target number of participants: 72
Treatments
Experimental: Mobile-Based Telemedicine + Routine Care
Arm 1 Arm Name: Intervention Group (Mobile-Based Telemedicine + Routine Care)~Description:~Participants in this arm will receive routine heart failure care provided at the cardiac clinic in addition to an 8-week mobile-based telemedicine intervention.~Intervention(s):~Behavioral Intervention: Mobile-Based Telemedicine Scheduled mobile phone calls SMS/text messages WhatsApp-based educational messages Health education on heart failure management Medication adherence support Diet and lifestyle counseling Symptom monitoring and follow-up support
Active_comparator: Routine Care Only
Arm 2 Arm Name: Control Group (Routine Care)~Description:~Participants in this arm will receive standard routine heart failure care provided at the cardiac clinic without additional mobile-based telemedicine support.~Intervention(s):~Standard Clinical Care Routine follow-up visits Usual medical management for chronic heart failure
Related Therapeutic Areas
Sponsors
Leads: Select College

This content was sourced from clinicaltrials.gov